N,N-diallyl-N-{[5-(1,4-dioxa-8-azaspiro[4,5]dec-8-ylsulfonyl)thien-2-yl]methyl}amine | 406486-96-2

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: N,N-diallyl-N-{[5-(1,4-dioxa-8-azaspiro[4,5]dec-8-ylsulfonyl)thien-2-yl]methyl}amine
• 英文别名: n,n-Diallyl-n-{[5-(1,4-dioxa-8-azaspiro[4.5]dec-8-ylsulfonyl)thien-2-yl]methyl}amine；N-[[5-(1,4-dioxa-8-azaspiro[4.5]decan-8-ylsulfonyl)thiophen-2-yl]methyl]-N-prop-2-enylprop-2-en-1-amine
• CAS: 406486-96-2
• 化学式: C₁₈H₂₆N₂O₄S₂
• 分子量: 398.547
• InChiKey: UGQYKTWSFNNLJZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  26
• 可旋转键数：
  8
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.56
• 拓扑面积：
  95.7
• 氢给体数：
  0
• 氢受体数：
  7

反应信息

• 作为反应物：
  描述：

  N,N-diallyl-N-{[5-(1,4-dioxa-8-azaspiro[4,5]dec-8-ylsulfonyl)thien-2-yl]methyl}amine 、 氯甲酸乙酯 在 叔丁基锂 作用下， 以 四氢呋喃 、 正己烷 为溶剂， 反应 0.08h， 以37%的产率得到ethyl 5-[(diallylamino)methyl]-2-(1,4-dioxa-8-azaspiro[4,5]dec-8-ylsulfonyl)thiophene-3-carboxylate
  参考文献：
  名称：

  Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein JunKinases

  摘要：

  本发明涉及具有基本亲水性磺胺基衍生物或具有基本亲水性基团的磺胺基衍生物，其化学式为I，特别用作药用活性化合物，以及含有这种磺胺基衍生物的药物配方。所述磺胺基衍生物是JNK途径的高效调节剂，特别是JNK 2和3的高效选择性抑制剂。本发明还涉及新型磺胺基衍生物以及其制备方法。 根据本发明的化学式I的化合物适用于药用剂的那些是： Ar1是取代或未取代的芳基或杂芳基； Ar2是携带至少一个亲水取代基的芳基或杂芳基； X是O或S，优选O； R1是氢或C1-C6烷基，或R1与Ar1形成取代或未取代的5-6元饱和或不饱和环； n是0到5之间的整数，优选在1-3之间，最优选1； 化学式I中的Y是未取代或取代的含有至少一个氮原子的4-12元饱和环或双环烷基，其中所述环中的一个氮原子与化学式I的磺酰基形成键合，从而提供磺胺基。

  公开号：

  EP1193267A1
• 作为产物：
  描述：

  4-哌啶酮缩乙二醇 、 N,N-diallylthiophen-2-ylmethylamine 在 叔丁基锂 、 二氧化硫 、 N-氯代丁二酰亚胺 、 三乙胺 作用下， 以 乙醚 、 正戊烷 为溶剂， 反应 2.42h， 以83%的产率得到N,N-diallyl-N-{[5-(1,4-dioxa-8-azaspiro[4,5]dec-8-ylsulfonyl)thien-2-yl]methyl}amine
  参考文献：
  名称：

  Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein Junkinases

  摘要：

  本发明涉及具有亲脂基团并在生理条件下基本可溶的磺胺基衍生物。所述化合物特别适用作药用活性化合物。本发明还涉及含有这种磺胺基衍生物的药物配方。所述磺胺基衍生物是JNK途径的高效调节剂，特别是JNK 2和3的高效和选择性抑制剂。本发明还涉及新型磺胺基衍生物以及它们的制备方法。 根据本发明的式I化合物适用于药用剂的那些化合物是这样的： Ar1和Ar2分别独立地是取代或未取代的芳基或杂环芳基， X是O或S，优选为O； R1是氢或C1-C6烷基，或R1与Ar1形成取代或未取代的5-6元饱和或不饱和环； n是0到5的整数，优选为1-3之间，最优选为1； 式I中的Y是未取代或取代的4-12元饱和环或双环烷基，其上取代有至少一个可离子化基团，该基团连接有一个亲脂链，并且含有至少一个氮原子，其中所述环中的一个氮原子与式I的磺酰基形成键合，从而提供磺胺基。

  公开号：

  EP1193268A1

文献信息

• Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein junkinases
  申请人：——

  公开号：US20040077632A1

  公开（公告）日：2004-04-22

  The present invention is related to substantially hydrophilic sulfonamide derivatives, or sulfonamide derivatives having a substantially hydrophilic moiety, of formula I notably for use as pharmaceutically active compounds, as well as to pharmaceutical formulations containing such sulfonamide derivatives. Said sulfonamide derivatives are efficient modulators of the JNK pathway, they are in particular efficient and selective inhibitors of JNK 3. The present invention is furthermore related to novel sulfonamide derivatives as well as to methods of their preparation. 1 The compounds of formula I according to the present invention being suitable pharmaceutical agents are those wherein Ar 1 is a substituted or unsubstituted aryl or heteroaryl; Ar 2 is an aryl or heteroaryl group carrying at least one hydrophilic substituent; X is O or S, preferably O; R 1 is hydrogen or a C 1 -C 6 -alkyl group, or R 1 forms a substituted or unsubstituted 5-6-membered saturated or unsaturated ring with Ar 1 ; n is an integer from 0 to 5, preferably between 1-3 and most preferred 1; Y within formula I is an unsubstituted or a substituted 4-12-membered saturated cyclic or bicyclic alkyl containing at least one nitrogen atom, whereby one nitrogen atom within said ring is forming a bond with the sulfonyl group of formula I thus providing a sulfonamide.

  本发明涉及具有基本亲水性磺酰胺衍生物或具有基本亲水性基团的磺酰胺衍生物的公式I，特别是作为药物活性化合物的使用，以及包含这些磺酰胺衍生物的制药配方。所述磺酰胺衍生物是JNK途径的有效调节剂，特别是JNK 3的有效和选择性抑制剂。本发明还涉及新的磺酰胺衍生物及其制备方法。根据本发明适合作为药物剂的公式I化合物是其中Ar1是取代或未取代的芳基或杂芳基；Ar2是携带至少一个亲水性取代基的芳基或杂芳基；X是O或S，优选为O；R1是氢或C1-C6烷基，或R1与Ar1形成取代或未取代的5-6成员饱和或不饱和环；n是0到5的整数，优选为1-3，最优选为1；公式I中的Y是未取代或取代的4-12成员饱和环或双环烷基，其中至少有一个氮原子，该氮原子在所述环中与公式I的磺酰基形成键，从而提供磺酰胺。
• Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moietties as inhibitors of protein junkinases
  申请人：——

  公开号：US20040077854A1

  公开（公告）日：2004-04-22

  The present invention is related to sulfonamide derivatives having a lipophilic moiety and which are substantially soluble. Said compounds are notably for use as pharmaceutically active compounds. The present invention also related to pharmaceutical formulations containing such sulfonamide derivatives. Said sulfonamide derivatives are efficient modulators of the JNK pathway, they are in particular efficient and selective inhibitors of JNK 2 and 3. The present invention is furthermore related to novel sulfonamide derivatives as well as to methods of their preparation. The compounds of formula (I) according to the present invention being suitable pharmaceutical agents are those wherein Ar1 and Ar2 are independently from each other substituted or unsubstituted aryl or heteroaryl groups, X is O or S, preferably O;R1 is hydrogen or a C1-C6-alkyl group, or R1 forms a substituted or unsubstituted 5-6-membered saturated or unsaturated ring with Ar1;n is an integer from 0 to 5, preferably between 1-3 and most preferred 1;Y within formula (I) is an unsubstituted or a substituted 4-12-membered saturated cyclic or bicyclic alkyl which is substituted with at least one ionisable moiety to which a lipophilic chain is attached and which is containing at least one nitrogen atom, whereby one nitrogen atom within said ring is forming a bond with the sulfonyl group of formula (I) thus providing a sulfonamide.

  本发明涉及具有亲脂基团且基本溶解的磺酰胺衍生物，该化合物特别适用于作为药物活性化合物。本发明还涉及含有这种磺酰胺衍生物的药物制剂。该磺酰胺衍生物是JNK途径的有效调节剂，尤其是JNK2和3的有效和选择性抑制剂。本发明还涉及新的磺酰胺衍生物以及它们的制备方法。本发明所述的公式（I）化合物适用于药物制剂，其中Ar1和Ar2分别是取代或未取代的芳基或杂环芳基基团，X为O或S，优选为O；R1为氢或C1-C6烷基，或R1与Ar1形成取代或未取代的5-6元饱和或不饱和环；n为0到5的整数，优选为1-3，最优选为1；公式（I）中的Y是未取代或取代的4-12元饱和环或双环烷基，其被至少一个离子化基团取代，并连接有一个亲脂链，并且含有至少一个氮原子，其中该环中的一个氮原子与公式（I）中的磺酰基形成键合，从而提供磺酰胺。
• Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein JunKinases
  申请人：Laboratoires Serono SA

  公开号：US07544700B2

  公开（公告）日：2009-06-09

  The present invention is related to sulfonamide derivatives having a lipophilic moiety and which are substantially soluble. Said compounds are notably for use as pharmaceutically active compounds. The present invention also related to pharmaceutical formulations containing such sulfonamide derivatives. Said sulfonamide derivatives are efficient modulators of the JNK pathway, they are in particular efficient and selective inhibitors of JNK 2 and 3. The present invention is furthermore related to novel sulfonamide derivatives as well as to methods of their preparation. The compounds of formula (I) according to the present invention being suitable pharmaceutical agents are those wherein Ar1 and Ar2 are independently from each other substituted or unsubstituted aryl or heteroaryl groups, X is O or S, preferably O; R1 is hydrogen or a C1-C6-alkyl group, or R1 forms a substituted or unsubstituted 5-6-membered saturated or unsaturated ring with Ar1; n is an integer from 0 to 5, preferably between 1-3 and most preferred 1; Y within formula (I) is an unsubstituted or a substituted 4-12-membered saturated cyclic or bicyclic alkyl which is substituted with at least one ionizable moiety to which a lipophilic chain is attached and which is containing at least one nitrogen atom, whereby one nitrogen atom within said ring is forming a bond with the sulfonyl group of formula (I) thus providing a sulfonamide.

  本发明涉及具有亲脂基团且基本可溶的磺酰胺衍生物，该化合物特别适用于作为药物活性化合物。本发明还涉及包含这种磺酰胺衍生物的制药配方。所述磺酰胺衍生物是JNK通路的高效调节剂，特别是JNK 2和3的高效和选择性抑制剂。本发明还涉及新型磺酰胺衍生物以及其制备方法。根据本发明适用于制药剂的化合物为公式（I）中Ar1和Ar2是独立的取代或未取代的芳基或杂环芳基基团，X为O或S，优选为O；R1为氢或C1-C6烷基，或R1与Ar1形成取代或未取代的5-6元饱和或不饱和环，n为0至5的整数，优选为1-3，最优选为1；公式（I）中的Y是未取代或取代的4-12元饱和环或双环烷基，其被至少一个离子化基团取代，该基团附着有亲脂链，并且至少含有一个氮原子，其中环内的一个氮原子与公式（I）中的磺酰基形成键，从而提供磺酰胺。
• Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of Protein Jun-kinases
  申请人：Merck Serono SA

  公开号：EP1322642B1

  公开（公告）日：2013-09-04
• PHARMACEUTICALLY ACTIVE HYDROPHILIC SULFONAMIDE DERIVATIVES AS INHIBITORS OF PROTEIN JUNKINASES
  申请人：Merck Serono SA

  公开号：EP1322641B1

  公开（公告）日：2012-07-25